Aktuella utlysningar, vecka 33, 2021
Grants Office tipsar om aktuella utlysningar
Svenska och nordiska anslag
Research grant – Tore Nilsons Foundation for Medical Research
These support clinical medical research. Grants are worth up to SEK 100,000 for a maximum of three years. Researchers who have defended their dissertations no more than five years ago can apply. Researchers who have not yet established themselves as recipients of regular grants from medical research's regular funding bodies are given priority. Maximum award: SEK 100,000
Closing date: 1 September 2021
Forskningstjänster inom ämnesområdet funktionshinder – Stiftelsen Promobilia
Stiftelsen Promobilia inbjuder ansökningar om anslag till forskningstjänster inom ämnesområdet funktionshinder. Dessa stöder forskare inom ämnesområdet funktionshinder. Forskning från alla discipliner uppmuntras, förutsatt att forskningsområdet involverar utveckling av hjälpmedel för funktionshindrade. Två typer av forskartjänster utlyses: doktorandtjänst med anslagstid två år och möjlighet till förlängning med ytterligare två år eller till disputation, där stöd uppgår till SEK 650,000 per år; postdoktorstjänst, med anslagstid två år och möjlighet till förlängning med ett år, där stöd uppgår till 800,000 per år.
Closing date: 9 September 2021
Reserach grants – Alzheimer’s Foundation
The Alzheimer's Foundation invites applications for grants for scientific research. This supports research in the field of Alzheimer's disease and other dementia diseases. Eligible to apply are PhD researchers at universities or equivalent educational institutions as well as doctoral students who have completed part-time control. Junior researchers who are in the process of qualifying for an associate professorship are especially encouraged to apply.
Closing date: 10 September 2021
Research grant in geriatrics – Gun och Bertil Stohne Foundation
This supports a person during their doctoral studies in the subject areas of geriatrics for one year. Grants are usually worth up to SEK 100,000.
Closing date: 13 September 2021
Industrial PhD in the public sector – Innovation Fund Denmark
This aims to give students the opportunity to conduct a research project in partnership with a private company, with the aim of strengthening the relationship between universities and the private sector. Funding partially covers the company’s expenses for the PhD student’s salary and travel-related expenses, as well as the university’s expenses for the project. Maximum award: DKK 1,194,000
Closing date: 21 September 2021
Mobility Grants for Internationalisation – STINT
This aims to strengthen Swedish research and higher education by developing and establishing international partnerships. The programme supports projects of high scientific quality which are clearly contributing to the activities of participating institutions. Applicants should have obtained their PhD as well as be employed and active at a Swedish university. Projects may last for up to three years. The proposed project must encompass at least one Swedish and at least one foreign party. The foreign party is required to co-fund the project on a corresponding level as applied for from STINT. The principal collaborating party shall be outside the EU/EFTA and the UK.
Closing date: 24 September 2021
Forskningsanslag – Stiftelsen Läkare Mot AIDS Forskningsfond
Stiftelsen Läkare Mot AIDS Forskningsfond stöder forskning kring HIV-infektion och AIDS, särskilt aspekter avseende behandling och prevention och vaccin. Prioritet ges till projekt som har klinisk anknytning och till sökande som nyligen påbörjat sin forskning. Stöd ges normalt bara till forskning som har en tydlig anknytning till ett svenskt universitet eller sjukhus.
Closing date: 1 October 2021
Mobility for innovation, learning and knowledge exchange 2021 – Vinnova
Vinnova offers funding to give people active in research and innovation the opportunity to work in an organization other than their current one. The purpose is to strengthen contacts, insights and collaboration as well as competence, knowledge and experience exchanges between organizations through a stay in another organization.
Closing date: 5 October 2021
Pioneer innovator grants – Novo Nordisk Foundation
These support application-oriented research within the life sciences in order to test ideas that may lead to the development of new medical treatments or health technologies, disease prevention, diagnostic methods, industrial biotechnology or devices. Grants are worth up to DKK 1 million each for 12 months. Maximum award: DKK 1,000,000
Closing date: 8 October 2021
Research grants - European Society of Clinical Microbiology and Infectious Diseases
The European Society of Clinical Microbiology and Infectious Diseases invites applications for its research grants. These enable young investigators to conduct research in the fields of infectious diseases and bacterial infections. Research projects may consist of laboratory investigations, clinical studies, experimental animal studies or a combination of these.
Applicants must be principal investigators of the proposed research and must have a medical degree, a PhD or be enrolled in a PhD programme. They must be ESCMID members and must have been born on or after 1 January 1982.
Grants are worth up to €20,000 each over a typical period of 12 months. Two grants, worth €50,000 each, are available for exceptional projects.
Closing date: 10 September 2021
The Cure Parkinson’s Trust invites applications for its research grants. These support laboratory or clinical research projects that have the potential to advance knowledge that might lead to a cure for Parkinson’s disease. Applications must be for research that slows, stops or reverses underlying disease progression. Priority is given to research which has potential to translate into the clinic within five years.
Applications are invited world wide. There is no set financial limit but grants are usually worth between £50,000 to £250,000 each over a period of one to three years.
Closing date: 1 October 2021
Starting grants - Frick Foundation for ALS Research
The Frick Foundation for ALS Research invites applications for its starting grants. These support basic biomedical research related to amyotrophic lateral sclerosis.
Applicants may be researchers of any nationality with five years of postdoctoral experience and potential to be a research leader. Research must be conducted in a public or private research organisation. Grants are worth CHF 100,000 over two years
Closing date: 30 September 2021
Global grants for gut health – Nature
Nature, with support from Yakult and Nature Research, invites applications for its global grants for gut health. These support research projects that advance understanding of the role of the early life microbiome in human health.
Researchers who are employed by a university, research institution or any other not-for-profit organisations across the world may apply. Applicants must hold a doctorate or medical degree and have at least five years of postdoctoral research experience. All nationalities are eligible. Up to three grants are available, each worth up to USD 100,000.
Closing date: 15 September 2021
Federal Funding agencies
Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP), Department of Defense, US
To meet the intent of the FY21 TBIPHRP Clinical Research Development Award (CRDA), applications must address at least one sub-area within one of the two FY21 TBIPHRP CRDA Focus Areas listed below. Selection of the appropriate FY21 TBIPHRP CRDA Focus Area is the responsibility of the applicant:
- Prevent: Research will address the prevention or progression of TBI or psychological health conditions through population, selective, and indicated prevention approaches. Efforts that focus on primary prevention (including protection), screening, diagnosis, and prognosis are within scope.
- Treat: Research will address immediate and long-term treatments and improvements in systems of care, including access to and delivery of healthcare services. Treatment topics may include novel treatments and interventions, personalized medicine approaches, length and durability of treatment, rehabilitation, relapse, and relapse prevention.
There are also other awards available:
- Clinical Trial Award (CTA): LOI: September 15, 2021. Full Application: December 16, 2021;
- Focused Program Award (FPA): LOI: September 15, 2021. Full Application: December 16, 2021;
- Idea Development Award (IDA): LOI: September 8, 2021. Application: September 30, 2021;
- Investigator-Initiated Research Award (IIRA): LOI: September 8, 2021. Application: September 30, 2021;
- Translational Research Award (TRA): LOI: September 15, 2021. Full Application: December 16, 2021.
Deadline: Clinical Research Development Award (CRDA): LOI: September 8, 2021. Application: September 30, 2021.
Funding Opportunity Number: W81XWH-21-TBIPHRP-CRDA
Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required), NIH
This Funding Opportunity Announcement (FOA) solicits mechanism-focused dementia care and caregiver support intervention development research at Stages I through V of the NIH Stage Model to address the care needs and promote the health, function, and well-being of persons with Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) and of those providing their care. The NIH Stage Model offers a framework to: (1) support development of efficacious interventions that are defined by their principles; and (2) ensure that these efficacious interventions can be administered in the community or in health systems with fidelity to the intervention’s principles. This includes the development, testing, and validation of scalable training materials and procedures so that these interventions can be delivered with fidelity in community settings or health systems. Settings can include the home, community, or formal care settings, such as nursing homes, assisted living facilities, nursing and rehabilitation centers, hospitals, adult day care, and specialized hospice settings. The overarching purpose of this FOA is to help to lay the groundwork for real-world implementation of AD/ADRD care and caregiving interventions.
Deadline: October 07, 2021, February 10, 2022, October 11, 2022, February 10, 2023, October 10, 2023, February 13, 2024 by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-21-307
Clinical and Biological Measures of TBI-related Dementia Including Chronic Traumatic Encephalopathy (R01 Clinical Trial Not Allowed), NIH
This FOA invites investigation of biological and clinical measures of TBI-related progressive neurodegeneration and neurocognitive decline associated with increased risk for dementia and /or traumatic encephalopathy syndrome (TES) (clinicopathologic diagnostic counterpart to the neuropathological diagnosis of Chronic Traumatic Encephalopathy (CTE)). Investigations should be based on existing, well-characterized populations of patients with a history of TBI that are enriched for increased risk of cognitive impairment or dementia and can continue to be followed longitudinally; additional subjects may be recruited as appropriate. The overall goal is to advance knowledge of the underlying pathophysiology and clinical characterization of the chronic effects of TBI that distinguish static-chronic TBI cognitive impairment from those that lead to progressive neurodegeneration associated with TES and dementia. A critical feature of this FOA includes the broad sharing of clinical, neuroimaging, physiological, and biospecimen data and to create a data and associated biofluid resource for the broader community to further advance research in this area.
Deadline: November 10, 2021 by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): PAR-22-024
Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional), NIH
The purpose of this UG3/UH3 Phased Innovation Award Funding Opportunity Announcement is to support research to understand and respond to the new challenges in treating drug addiction and overdose, introduced by the presence of fentanyl and its analogs (fentanyls) in illicit drug supplies.
Applications should focus on understanding and treating opioid and polydrug use disorders (including overdose), wherein fentanyls are a major contributor and their presence has altered previous estimations of the scope, impact and treatment of the problem. The research may include preclinical, clinical, epidemiological or even post-mortem studies. Studies should have high significance in order to quickly yield improvements in understanding and to provide effective responses to the problems caused by illicit fentanyls.
Deadline: November 10, 2021 by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-DA-22-022
CRI Irvington Postdoctoral Fellowship Program, Cancer Research Institute, US
The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology. CRI seeks hypothesis-driven, mechanistic studies in both immunology and tumor immunology. The applicant and sponsor should make every effort to demonstrate the potential of the proposed studies to directly impact our understanding of the immune system’s role in cancer. Newly awarded fellowships provide a stipend of $55,000 for the first year, $57,000 for the second year, and $59,000 for the third year. In addition, an allowance of $1,500 per year is allotted to the host institution for use at the sponsor’s discretion to help pay for the fellow’s research supplies, travel to scientific meetings, and/or health insurance.
Deadline: October 1.